259
Views
8
CrossRef citations to date
0
Altmetric
IN VITRO FERTILIZATION

Evaluation of granulocyte colony-stimulating factor on the treatment of thin endometrium during frozen-thawed embryo transfer cycles: a retrospective cohort study

, , , , ORCID Icon & ORCID Icon
Pages 370-374 | Received 08 Feb 2019, Accepted 18 Aug 2019, Published online: 29 Aug 2019

References

  • Kovacs P, Matyas S, Boda K, et al. The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod. 2003;18:2337–2341.
  • Traub ML, Van Arsdale A, Pal L, et al. Endometrial thickness, Caucasian ethnicity, and age predict clinical pregnancy following fresh blastocyst embryo transfer: a retrospective cohort. Reprod Biol Endocrinol. 2009;7:33.
  • Al-Ghamdi A, Coskun S, Al-Hassan S, et al. The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome. Reprod Biol Endocrinol. 2008;6:37.
  • Dix E, Check JH. Successful pregnancies following embryo transfer despite very thin late proliferative endometrium. Clin Exp Obstet Gynecol. 2010;37:15–16.
  • Singh N, Bahadur A, Mittal S, et al. Predictive value of endometrial thickness, pattern and sub-endometrial blood flows on the day of hCG by 2D doppler in in-vitro fertilization cycles: a prospective clinical study from a tertiary care unit. J Hum Reprod Sci. 2011;4:29–33.
  • Kasius A, Smit JG, Torrance HL, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update. 2014;20:530–541.
  • Revel A. Defective endometrial receptivity. Fertil Steril. 2012;97:1028–1032.
  • Hsieh Y-Y, Tsai H-D, Chang C-C, et al. Low-dose aspirin for infertile women with thin endometrium receiving intrauterine insemination: a prospective, randomized study. J Assist Reprod Genet. 2000;17:174–177.
  • Zinger M, Liu JH, Thomas MA. Successful use of vaginal sildenafil citrate in two infertility patients with Asherman's syndrome. J Womens Health (Larchmt). 2006;15:442–444.
  • Shen M-S, Wang C-W, Chen C-H, et al. New horizon on successful management for a woman with repeated implantation failure due to unresponsive thin endometrium: use of extended estrogen supplementation. J Obstet Gynaecol Res. 2013;39:1092–1094.
  • Venetis CA, Kolibianakis EM, Bosdou JK, et al. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update. 2013;19:433–457.
  • Acharya S, Yasmin E, Balen AH. The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies–a report of 20 cases. Hum Fertil (Camb). 2009;12:198–203.
  • Letur-Konirsch H, Delanian S. Successful pregnancies after combined pentoxifylline-tocopherol treatment in women with premature ovarian failure who are resistant to hormone replacement therapy. Fertil Steril. 2003;79:439–441.
  • Zhao J, Zhang Q, Wang Y, et al. Uterine infusion with bone marrow mesenchymal stem cells improves endometrium thickness in a rat model of thin endometrium. Reprod Sci. 2015;22:181–188.
  • Barash A, Dekel N, Fieldust S, et al. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril. 2003;79:1317–1322.
  • Ledee N, Lombroso R, Lombardelli L, et al. Cytokines and chemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor. Hum Reprod. 2008;23:2001–2009.
  • Ledee N, Petitbarat M, Rahmati M, et al. New pre-conception immune biomarkers for clinical practice: interleukin-18, interleukin-15 and TWEAK on the endometrial side, G-CSF on the follicular side. J Reprod Immunol. 2011;88:118–123.
  • Litwin S, Lagadari M, Barrientos G, et al. Comparative immunohistochemical study of M-CSF and G-CSF in feto-maternal interface in a multiparity mouse model. Am J Reprod Immunol. 2005;54:311–320.
  • Tanaka T, Miyama M, Masuda M, et al. Production and physiological function of granulocyte colony-stimulating factor in non-pregnant human endometrial stromal cells. Gynecol Endocrinol. 2000;14:399–404.
  • Rutella S, Zavala F, Danese S, et al. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunol. 2005;175:7085–7091.
  • Salmassi A, Schmutzler AG, Huang L, et al. Detection of granulocyte colony-stimulating factor and its receptor in human follicular luteinized granulosa cells. Fertil Steril. 2004;81:786–791.
  • Uzumaki H, Okabe T, Sasaki N, et al. Identification and characterization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells. Proc Natl Acad Sci USA. 1989;86:9323–9326.
  • Gleicher N, Vidali A, Barad DH. Successful treatment of unresponsive thin endometrium. Fertil Steril. 2011;95:2123 e13–7.
  • Gleicher N, Kim A, Michaeli T, et al. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum Reprod. 2013;28:172–177.
  • Mahajan N, Sharma S. The endometrium in assisted reproductive technology: How thin is thin? J Hum Reprod Sci. 2016;9:3–8.
  • Dehbashi S, Parsanezhad ME, Alborzi S, et al. Effect of clomiphene citrate on endometrium thickness and echogenic patterns. Int J Gynaecol Obstet. 2003;80:49–53.
  • Haritha S, Rajagopalan G. Follicular growth, endometrial thickness, and serum estradiol levels in spontaneous and clomiphene citrate-induced cycles. Int J Gynaecol Obstet. 2003;81:287–292.
  • Miwa I, Tamura H, Takasaki A, et al. Pathophysiologic features of “thin” endometrium. Fertil Steril. 2009;91:998–1004.
  • Gao M, Cao C, Zhang X, et al. Abnormal expression of estrogen receptor is associated with thin endometrium. Gynecol Endocrinol. 2019;35:544–547.
  • Barad DH, Yu Y, Kushnir VA, et al. A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates. Fertil Steril. 2014;101:710–715.
  • Kunicki M, Łukaszuk K, Woclawek-Potocka I, et al. Evaluation of granulocyte colony-stimulating factor effects on treatment-resistant thin endometrium in women undergoing in vitro fertilization. Biomed Res Int. 2014;2014:1.
  • Lucena E, Moreno-Ortiz H. Granulocyte colony-stimulating factor (G-CSF): a mediator in endometrial receptivity for a patient with polycystic ovary (PCO) undergoing in vitro maturation (IVM). BMJ Case Rep. 2013;2013:bcr2012008115.
  • Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod. 2009;24:2703–2708.
  • Wurfel W, Santjohanser C, Hirv K, et al. High pregnancy rates with administration of granulocyte colony-stimulating factor in ART-patients with repetitive implantation failure and lacking killer-cell immunglobulin-like receptors. Hum Reprod. 2010;25:2151–2152 (author reply 2152).
  • Li Y, Pan P, Chen X, et al. Granulocyte colony-stimulating factor administration for infertile women with thin endometrium in frozen embryo transfer program. Reprod Sci. 2014;21:381–385.
  • Xu B, Zhang Q, Hao J, et al. Two protocols to treat thin endometrium with granulocyte colony-stimulating factor during frozen embryo transfer cycles. Reprod Biomed Online. 2015;30:349–358.
  • Eftekhar M, Sayadi M, Arabjahvani F. Transvaginal perfusion of G-CSF for infertile women with thin endometrium in frozen ET program: a non-randomized clinical trial. Iran J Reprod Med. 2014;12:661–666.
  • Kunicki M, Łukaszuk K, Liss J, et al. Granulocyte colony stimulating factor treatment of resistant thin endometrium in women with frozen-thawed blastocyst transfer. Syst Biol Reprod Med. 2017;63:49–57.
  • Vandermolen DT, Gu Y. Human endometrial expression of granulocyte colony-stimulating factor (G-CSF) and its receptor, stimulation of endometrial G-CSF production by interleukin-1 beta, and G-CSF inhibition of choriocarcinoma cell proliferation. Am J Reprod Immunol. 1996;36:278–284.
  • Furmento VA, Marino J, Blank VC, et al. The granulocyte colony-stimulating factor (G-CSF) upregulates metalloproteinase-2 and VEGF through PI3K/Akt and Erk1/2 activation in human trophoblast Swan 71 cells. Placenta. 2014;35:937–946.
  • Miyama M, Umesaki N, Kawabata M. Identification of the granulocyte colony-stimulating factor (G-CSF) producing cell population in human decidua and its biological action on trophoblast cell. Osaka City Med J. 1998;44:85–96.
  • Davari-Tanha F, Shahrokh Tehraninejad E, Ghazi M, et al. The role of G-CSF in recurrent implantation failure: A randomized double blind placebo control trial. IJRM. 2016;14:737–742.
  • Salmassi A, Schmutzler AG, Schaefer S, et al. Is granulocyte colony-stimulating factor level predictive for human IVF outcome?. Hum Reprod. 2005;20:2434–2440.
  • Santjohanser C, Knieper C, Franz C, et al. Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage. Arch Immunol Ther Exp (Warsz). 2013;61:159–164.
  • Zhao J, Tian T, Zhang Q, et al. Use of granulocyte colony-stimulating factor for the treatment of thin endometrium in experimental rats. PLOS One. 2013;8:e82375.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.